Outcomes of Bilateral Implantation of an Enhanced Monofocal Intraocular Lens

Inclusion Criteria: * clinically significant bilateral cataract (BCVA \<20/40, cataract must be the primary cause of visual impairment) * axial length between 21 and 27 mm * the patient must be able to read, understand and provide written informed consent, * the patient must be willing and able to comply with all study and follow-up procedures * preoperative refractive cylinder ≤ 0.75 D Exclusion Criteria: * anterior segment pathology that could significantly affect results (e.g., chronic uveitis, iritis, corneal dystrophy, keratoconus) * diabetic retinopathy * uncontrolled glaucoma and/or intraocular pressure IOP\> 24 mmHg * all types of infections (acute eye disease, external/internal infection, systemic infection) * traumatic cataract * pupillary abnormalities including aniridia and/or pupil diameter in mesopic conditions in distance vision ≤ 2.5 mm and ≥ 6 mm * microphthalmia * amblyopia * degenerative visual disorders (for example macular degeneration, optic nerve atrophy or retinal disorders) * previous intraocular and corneal surgery * systemic or ocular pharmacotherapy, which may impact visual acuity and/or cause floppy iris syndrome and/or insufficient dilation in the opinion of the investigator * patients who are unable to fixate for a prolonged time (e.g. strabismus, nystagmus) * period of pregnancy or breastfeeding for female patients